Inflammatory vs. Non-inflammatory Acute Gastroenteritis
Key Clinical Distinction
Inflammatory and non-inflammatory acute gastroenteritis differ fundamentally in their pathophysiology, clinical presentation, and management approach—with inflammatory diarrhea requiring more aggressive evaluation and selective antimicrobial therapy, while non-inflammatory diarrhea is managed primarily with supportive care alone. 1, 2
Pathophysiology and Causative Organisms
Non-inflammatory Diarrhea
- Mechanism: Caused by enterotoxin-producing organisms or viruses that adhere to the mucosa and disrupt absorptive/secretory processes without causing acute inflammation or mucosal destruction 2
- Common pathogens:
Inflammatory Diarrhea
- Mechanism: Results from either cytotoxin-producing non-invasive bacteria that activate cytokines and inflammatory mediators, or invasive organisms that penetrate the intestinal mucosa inducing acute inflammatory reactions 2
- Common bacterial pathogens (in order of frequency in children):
Clinical Presentation
Non-inflammatory Diarrhea Features
- Stool characteristics: Large-volume, watery diarrhea without blood or mucus 1
- Systemic symptoms: Generally mild fever or afebrile 3
- Abdominal findings: Cramping without severe focal tenderness 1
- Duration: Typically self-limited, resolving within 7 days 1
Inflammatory Diarrhea Features
- Stool characteristics: Frequent, small-volume stools with blood and mucus (dysentery pattern) 1
- Systemic symptoms: Fever (though mean temperature may only be 37.5°C in bacterial cases) 3
- Abdominal findings: More severe abdominal pain (mean duration 1.8 days from onset) 3
- Stool frequency: Average 9.3 unformed stools per day in bacterial cases 3
- Important caveat: Only 10.8% of bacterial gastroenteritis cases present with bloody diarrhea, so absence of blood does not exclude inflammatory etiology 3
Diagnostic Approach
When to Test
Laboratory investigation is not warranted for most acute diarrhea in previously healthy, immunocompetent individuals with mild symptoms lasting <7 days 1
Indications for testing include: 1, 4
- Bloody stools
- Severe symptoms or signs of sepsis
- Duration >7 days
- Immunocompromised patients
- Recent antibiotic exposure (test for C. difficile)
- Suspected outbreak situation
- Patients with underlying disease
Diagnostic Tests
Inflammatory markers can differentiate between types: 5, 6
- Procalcitonin: Best discriminatory marker (AUC 0.797) with 87% sensitivity and 69% specificity at cutoff 0.08 ng/mL 5
- CRP: Elevated in inflammatory diarrhea; useful for identifying bacterial AGE requiring antibiotics 6
- WBC count: Higher in inflammatory cases; helpful in predicting ED revisits 6
- Absolute neutrophil count: Elevated in inflammatory diarrhea 5
- Multiplex antimicrobial testing is now preferred over traditional stool cultures 4
- Stool cultures remain important for antibiotic sensitivity data and outbreak investigations 8
- Blood cultures indicated in patients with signs of severe disease 7
Management Differences
Universal Supportive Care (Both Types)
Rehydration (cornerstone of all gastroenteritis management): 1
- Oral rehydration solution (ORS) for mild-to-moderate dehydration until clinical dehydration corrected 1
- Intravenous isotonic fluids (lactated Ringer's or normal saline) for severe dehydration, shock, altered mental status, or ORS failure 1
- Continue human milk feeding in infants throughout illness 1
- Resume age-appropriate diet immediately after rehydration 1
Antiemetics: 1
- Ondansetron may be given to children >4 years and adolescents with vomiting to facilitate oral rehydration 1
- Not routinely recommended for children <4 years or adults 1
Critical Management Distinction: Antimotility Agents
For non-inflammatory (watery) diarrhea: 1
- Loperamide may be given to immunocompetent adults with acute watery diarrhea 1
- Reduces diarrhea prevalence at 24 and 48 hours and shortens total duration 1
For inflammatory diarrhea: 1
- Loperamide must be avoided at any age in suspected or proven inflammatory diarrhea or diarrhea with fever due to risk of toxic megacolon 1
- Should never be given to children <18 years with acute diarrhea 1
Antimicrobial Therapy
Non-inflammatory diarrhea: 7
- Empirical antibiotics generally not indicated
- Supportive care alone is appropriate
Inflammatory diarrhea—selective antibiotic use: 7
Empirical therapy indicated for: 7
- Infants <3-6 months with suspected bacterial AGE
- Signs of sepsis
- Immunocompromised or institutionalized patients
- Underlying disease with risk of dissemination
Targeted therapy after identification: 7
- C. difficile: Always treat
- Non-Typhi Salmonella: Only treat if risk of systemic infection or prolonged diarrhea
- STEC: Antibiotics restricted to high-risk patients (controversial due to HUS risk)
- Campylobacter: Note high ciprofloxacin resistance (7 of 9 isolates in one study) 3
Important limitation: Stool culture results do not change management in 88.5% of bacterial gastroenteritis cases, as most are self-limited 3
Clinical Pitfalls
- Do not assume bloody diarrhea is always present in inflammatory gastroenteritis—only 10.8% of bacterial cases present with blood 3
- Do not use antimotility agents empirically—always exclude inflammatory diarrhea first by assessing for fever, bloody stools, or severe systemic symptoms 1
- Do not routinely order stool cultures for mild cases—reserve for severe, prolonged, or high-risk situations 1
- Campylobacter infections cause longer duration of abdominal pain (mean difference significant, p=0.024) but patients are less likely to be dehydrated 3